Literature DB >> 2113364

Studies on the formation, separation, and characterization of cyanogen bromide fragments of human AI apolipoprotein.

J R Morrison1, N H Fidge, B Grego.   

Abstract

We have sought to obtain conditions for cyanogen bromide (CNBr) cleavage of apolipoprotein AI which would preserve, as far as possible, the biological activity of the resulting fragments. We found that the choice of solvent is an important consideration since modification of amino acids in different proteins varies with cleavage conditions. Initially, an analytical technique employing reversed-phase (RP)-HPLC which separates the four CNBr fragments in a single chromatographic step was established to monitor the products and extent of cleavage. In developing this technique, spectral data indicated damage to tyrosine and tryptophan residues during CNBr digestion. This problem was resolved by using 70% trifluoroacetic acid instead of 70% formic acid as the solvent, which had the added benefit of increasing the extent of cleavage of the Met86-Ser87 bond by 50%. We applied the information derived from the analytical RP-HPLC method to achieve the preparative isolation of CNBr fragments. This procedure included a gel permeation chromatography step using a citrate/urea buffer before RP-HPLC to isolate pure fragments in volatile buffers. Finally, we discuss aspects of structural integrity with an emphasis on modification of aromatic amino acids and deamidation of asparagine and glutamine residues.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2113364     DOI: 10.1016/0003-2697(90)90588-z

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  5 in total

1.  Apolipoprotein A-I stimulates the transport of intracellular cholesterol to cell-surface cholesterol-rich domains (caveolae).

Authors:  D Sviridov; N Fidge; G Beaumier-Gallon; C Fielding
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

2.  A gel-based method for purification of apolipoprotein A-I from small volumes of plasma.

Authors:  Rachel J Brace; Brie Sorrenson; Dmitri Sviridov; Sally P A McCormick
Journal:  J Lipid Res       Date:  2010-07-27       Impact factor: 5.922

3.  Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties.

Authors:  A Hoang; A J Murphy; M T Coughlan; M C Thomas; J M Forbes; R O'Brien; M E Cooper; J P F Chin-Dusting; D Sviridov
Journal:  Diabetologia       Date:  2007-06-20       Impact factor: 10.122

4.  Monoclonal antibodies to human apolipoprotein AI: probing the putative receptor binding domain of apolipoprotein AI.

Authors:  C M Allan; N H Fidge; J R Morrison; J Kanellos
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

5.  High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation.

Authors:  Brian G Drew; Noel H Fidge; Gabrielle Gallon-Beaumier; Bruce E Kemp; Bronwyn A Kingwell
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-23       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.